In conclusion, we found that VAT aromatase activity is positively associated with VAT adipocyte hypertrophy and negatively with plasma HDL-c, while SAT aromatase activity predicted dyslipidemia in women even after adjustment for WC, age, and anovulant intake. The gene discussed is CYP19A1; the disease is metabolic syndrome.